Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (39083)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 28, 2017 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol 2017; 23(36): 6549-6570 [PMID: 29085205 DOI: 10.3748/wjg.v23.i36.6549] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i36/6549.htm |
| Number | Citing Articles |
| 1 |
Jinhui Sun, Baolong Li, Antao Sun, Kunpeng Zhao, Yanchun Ma, Jiuli Zhao, Hui Pan, Qingrui Song, Yan Wang, Chunyu Yu, Cui Wang, Huan Zhang, Wenwen Zhang, Chenfan Kong. Comprehensive analysis of aberrantly expressed profiles of messenger RNA in alcoholic liver disease. Journal of Cellular Biochemistry 2019; 120(3): 4248 doi: 10.1002/jcb.27710
|
| 2 |
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
|
| 3 |
Sara Redenšek Trampuž, Sander van Riet, Åsa Nordling, Magnus Ingelman-Sundberg. The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids. Cells 2023; 12(2): 302 doi: 10.3390/cells12020302
|
| 4 |
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, Nitesh Kumar, C. Mallikarjuna Rao. Epigenetics in NAFLD/NASH: Targets and therapy. Pharmacological Research 2021; 167: 105484 doi: 10.1016/j.phrs.2021.105484
|
| 5 |
Benedikt Kaufmann, Agustina Reca, Andrea D. Kim, Ariel E. Feldstein. Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications. Seminars in Liver Disease 2021; 41(02): 150 doi: 10.1055/s-0041-1723031
|
| 6 |
Rongsheng Wang, Jinji Mu. Arbutin attenuates ethanol‐induced acute hepatic injury by the modulation of oxidative stress and Nrf‐2/HO‐1 signaling pathway. Journal of Biochemical and Molecular Toxicology 2021; 35(10) doi: 10.1002/jbt.22872
|
| 7 |
Lin Zhu, Jie-Jie Xu, Hai-Di Li, Juan-Juan Li, Miao Cheng, Xue-Ni Niu, Peng-Cheng Jia, Jing-Yu Liu, Cheng Huang, Xiong-Wen Lv, Jun Li. Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate–Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease. Laboratory Investigation 2023; 103(4): 100041 doi: 10.1016/j.labinv.2022.100041
|
| 8 |
Cuiqing Zhao, Liming Liu, Qi Liu, Fengyuan Li, Lihua Zhang, Fenxia Zhu, Tuo Shao, Shirish Barve, Yiping Chen, Xiaokun Li, Craig J. McClain, Wenke Feng. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Molecular Metabolism 2019; 29: 145 doi: 10.1016/j.molmet.2019.08.020
|
| 9 |
Bum Hoi Kim. The Protective Effects of Silbi-um Extract on the Alcoholic Liver Injury in Rats. Journal of Korean Medicine for Obesity Research 2018; 18(2): 74 doi: 10.15429/jkomor.2018.18.2.74
|
| 10 |
Aiping Liu, Yitong Cai, Yuan Yuan, Ming Liu, Zhengjing Zhang, Yongquan Xu, Pingzu Jiao. Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis. Systematic Reviews 2023; 12(1) doi: 10.1186/s13643-023-02238-w
|
| 11 |
Irina A. Kirpich, Dennis R. Warner, Wenke Feng, Swati Joshi-Barve, Craig J. McClain, Devanshi Seth, Wei Zhong, Zhanxiang Zhou, Natalia A. Osna, Kusum K. Kharbanda. Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium. Alcohol 2020; 83: 105 doi: 10.1016/j.alcohol.2019.05.004
|
| 12 |
Parul Kamboj, Soumalya Sarkar, Sonu Kumar Gupta, Neema Bisht, Deepika Kumari, Md. Jahangir Alam, Sagar Barge, Bhaswati Kashyap, Barsha Deka, Simanta Bharadwaj, Seydur Rahman, Partha Pratim Dutta, Jagat C. Borah, Narayan Chandra Talukdar, Sanjay K. Banerjee, Yashwant Kumar. Methanolic Extract of Lysimachia Candida Lindl. Prevents High-Fat High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through Untargeted Metabolomics Study. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.653872
|
| 13 |
Kaviyarasi Renu, Haritha Myakala, Rituraj Chakraborty, Sharmishtha Bhattacharya, Asmita Abuwani, Mariyam Lokhandwala, Balachandar Vellingiri, Abilash Valsala Gopalakrishnan. Molecular mechanisms of alcohol's effects on the human body: A review and update. Journal of Biochemical and Molecular Toxicology 2023; 37(12) doi: 10.1002/jbt.23502
|
| 14 |
Nazish Butt, Muhammad Masood, Aamir Ali. Efficacy and Safety of Prunus mume and Choline in Patients with Nonalcoholic Fatty Liver Disease. Euroasian journal of hepato-gastroenterology 2023; 13(2): 124 doi: 10.5005/jp-journals-10018-1397
|
| 15 |
Su-Yeon Lee, Kyung-Sook Chung, So-Ri Son, So Young Lee, Dae Sik Jang, Jong-Kil Lee, Hyun-Jae Kim, Chang-Seon Na, Sun-Hee Lee, Kyung-Tae Lee. A Botanical Mixture Consisting of Inula japonica and Potentilla chinensis Relieves Obesity via the AMPK Signaling Pathway in 3T3-L1 Adipocytes and HFD-Fed Obese Mice. Nutrients 2022; 14(18): 3685 doi: 10.3390/nu14183685
|
| 16 |
Jian Yang, Yi Lei, Junlin Yan, Yewei Zhong, Adalaiti Abudurexiti, Huiwen Tan, Yinsong Ye, Rui Zhang, Fenglian Tong, Xiaoli Ma. Research Progress on the Homologous Effects of Cichorium glandulosum Boiss. et Huet on Medicine and Food: A Review. Natural Product Communications 2024; 19(4) doi: 10.1177/1934578X241248237
|
| 17 |
U. Maggi, M. Iavarone, M. Fabbi, D. Yiu, G. Fornoni, E. Melada, D. Dondossola, P. Cantù, G. Rossi. Liver Transplantations and Brain Dead Donors With Alcohol Abuse. Transplantation Proceedings 2018; 50(10): 3105 doi: 10.1016/j.transproceed.2018.08.023
|
| 18 |
Yifei Lu, Mingmei Shao, Hongjiao Xiang, Junmin Wang, Guang Ji, Tao Wu. Qinggan Huoxue Recipe Alleviates Alcoholic Liver Injury by Suppressing Endoplasmic Reticulum Stress Through LXR-LPCAT3. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.824185
|
| 19 |
Fei Guo, Rui Chen, Linghui Kong, Pan Wei, Ziyu Liu, Xiaoqing Wang, Hairong Hao, Yanwen Lu, Wen Hu. Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease. Hepatology International 2022; 16(6): 1424 doi: 10.1007/s12072-022-10387-8
|
| 20 |
Alessandro Federico, Marcello Dallio, Mario Masarone, Antonietta Gerarda Gravina, Rosa Di Sarno, Concetta Tuccillo, Valentina Cossiga, Stefania Lama, Paola Stiuso, Filomena Morisco, Marcello Persico, Carmelina Loguercio. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8742075
|
| 21 |
Sujan Chatterjee, Debajyoti Patra, Udipta Chakraborti, Dipanwita Sengupta, Pujita Ghosh, Anupam Basu, Gobinda Chandra Sadhukhan, Kaustav Dutta Chowdhury. Association of p38MAPK‐p53‐Fas aggregation in S‐allyl cysteine mediated regulation of hepatocarcinoma. Environmental Toxicology 2019; 34(8): 928 doi: 10.1002/tox.22764
|
| 22 |
Yuhao Wang, Yonglun Wang, Fang Li, Jie Zou, Xiaoqian Li, Mengxia Xu, Daojiang Yu, Yijia Ma, Wei Huang, Xiaodong Sun, Yuanyuan Zhang. Psoralen Suppresses Lipid Deposition by Alleviating Insulin Resistance and Promoting Autophagy in Oleate-Induced L02 Cells. Cells 2022; 11(7): 1067 doi: 10.3390/cells11071067
|
| 23 |
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica (English Edition) 2022; 158(11): 550 doi: 10.1016/j.medcle.2022.05.009
|
| 24 |
Qi Cheng, Yong-Wen Li, Cheng-Fang Yang, Yu-Juan Zhong, He He, Fang-chan Zhu, Li Li. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells. Chemico-Biological Interactions 2018; 291: 180 doi: 10.1016/j.cbi.2018.06.028
|
| 25 |
Junmin Wang, Jiacheng Li, Yugang Fu, Yingying Zhu, Liubing Lin, Yong Li. Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review). International Journal of Molecular Medicine 2024; 53(4) doi: 10.3892/ijmm.2024.5356
|
| 26 |
Xiaoli Fan, Jin Lin, Honglan Liu, Qiaoyu Deng, Yanyi Zheng, Xiaoze Wang, Li Yang. The role of macrophage-derived exosomes in noncancer liver diseases: From intercellular crosstalk to clinical potential. International Immunopharmacology 2024; 143: 113437 doi: 10.1016/j.intimp.2024.113437
|
| 27 |
Lea Ladegaard Grønkjær, Charlotte Wernberg, Mette Munk Lauridsen. Non-alcoholic fatty liver disease: the role of the nurse. Gastrointestinal Nursing 2020; 18(Sup6): S15 doi: 10.12968/gasn.2020.18.Sup6.S15
|
| 28 |
George Cholankeril, Chiranjeevi Gadiparthi, Eric R. Yoo, Brittany B. Dennis, Andrew A. Li, Menghan Hu, Katherine Wong, Donghee Kim, Aijaz Ahmed. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation 2019; 103(1): 131 doi: 10.1097/TP.0000000000002471
|
| 29 |
Ivan M. Petyaev, Marina P. Chernyshova, Dmitry V. Pristensky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle, Yuriy K. Bashmakov. Effect of Lycosome-Formulated Phosphatidylcholine on Parameters of Biological Oxidation after Single Intake of Moderate Amount of Alcohol. Advances in Preventive Medicine 2018; 2018: 1 doi: 10.1155/2018/5840451
|
| 30 |
Mengyi Liu, Sisi Yang, Ziliang Ye, Yuanyuan Zhang, Panpan He, Chun Zhou, Yanjun Zhang, Xianhui Qin. Residential green and blue spaces with nonalcoholic fatty liver disease incidence: Mediating effect of air pollutants. Ecotoxicology and Environmental Safety 2023; 264: 115436 doi: 10.1016/j.ecoenv.2023.115436
|
| 31 |
Huanhuan Ma, Yunxia Ma, Zeren Dawa, Yufeng Yao, Meiqi Wang, Kaihui Zhang, Chenchen Zhu, Fangle Liu, Chaozhan Lin. Diterpenoid Alkaloids Isolated from Delphinium brunonianum and Their Inhibitory Effects on Hepatocytes Lipid Accumulation. Molecules 2022; 27(7): 2257 doi: 10.3390/molecules27072257
|
| 32 |
Cheng Wang, Cheng Ma, Lihong Gong, Shu Dai, Yunxia Li. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. European Journal of Pharmacology 2021; 912: 174604 doi: 10.1016/j.ejphar.2021.174604
|
| 33 |
Galal A. AL-SAMHARI, Gaber M. AL-MUSHIKI, Rashi TAMRAKAR, Gibirima ABDULLAHI, YUE-Dong LIN, XIAN-Yan TANG. Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease. Journal of Nutritional Science and Vitaminology 2021; 67(6): 366 doi: 10.3177/jnsv.67.366
|
| 34 |
Devaraj Ezhilarasan, Karthik Shree Harini, Munusamy Karthick, Prathap Lavanya. Boldine protects against carbon tetrachloride‐induced chronic liver injury by regulating NF‐κB signaling pathway. Journal of Biochemical and Molecular Toxicology 2024; 38(4) doi: 10.1002/jbt.23691
|
| 35 |
Mengyao Hu, Yu Chen, Fan Deng, Bo Chang, Jialiang Luo, Lijun Dong, Xiao Lu, Yi Zhang, Zhengliang Chen, Jia Zhou. D-Mannose Regulates Hepatocyte Lipid Metabolism via PI3K/Akt/mTOR Signaling Pathway and Ameliorates Hepatic Steatosis in Alcoholic Liver Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.877650
|
| 36 |
Yu-xin Yao, Yu-jie Yu, Shu Dai, Chao-yang Zhang, Xin-yan Xue, Meng-ling Zhou, Chen-hao Yao, Yun-xia Li. Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis. Biomedicine & Pharmacotherapy 2024; 175: 116694 doi: 10.1016/j.biopha.2024.116694
|
| 37 |
Shuning Ding, Peipei Wang, Xi Pang, Leyin Zhang, Lihui Qian, Xinru Jia, Wenqian Chen, Shanming Ruan, Leitao Sun. The new exploration of pure total flavonoids extracted from Citrus maxima (Burm.) Merr. as a new therapeutic agent to bring health benefits for people. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.958329
|
| 38 |
Yiwen Zhang, Li Wang, Jiaqi He, Haoze Wang, Wenqi Xin, Houpeng Wang, Jianjun Zhang.
Antioxidation and Hepatoprotection of Selenium Mycelium Polysaccharides Against Alcoholic Liver Diseases from the Cultivated Morel Mushroom Morchella esculenta (Ascomycota)
. International Journal of Medicinal Mushrooms 2024; 26(1): 55 doi: 10.1615/IntJMedMushrooms.2023051288
|
| 39 |
Yeoree Yang, Jae-Hyoung Cho. Higher Weight Variability Could Bring You a Fatty Liver. Endocrinology and Metabolism 2021; 36(4): 766 doi: 10.3803/EnM.2021.403
|
| 40 |
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica 2022; 158(11): 550 doi: 10.1016/j.medcli.2021.12.003
|
| 41 |
Jiaoyan Ren, Wanqian Sha, Shuaiming Shang, Erdong Yuan. Hepatoprotective peptides purified from Corbicula fluminea and its effect against ethanol‐induced LO2 cells injury. International Journal of Food Science & Technology 2021; 56(1): 352 doi: 10.1111/ijfs.14649
|
| 42 |
Shao-wei Han, Xiao-juan Wang, Bao-song Cui, Hua Sun, Hui Chen, Daneel Ferreira, Shuai Li, Mark T. Hamann. Hepatoprotective Glucosyloxybenzyl 2-Hydroxy-2-isobutylsuccinates from Pleione yunnanensis. Journal of Natural Products 2021; 84(3): 738 doi: 10.1021/acs.jnatprod.0c01117
|
| 43 |
Yue Gao, Shujun Zhang, Jiajun Li, Jinqiu Zhao, Qing Xiao, Yali Zhu, Jia Zhang, Wenxiang Huang. Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid. Bioscience, Biotechnology, and Biochemistry 2020; 84(11): 2228 doi: 10.1080/09168451.2020.1793293
|
| 44 |
Ron Nafshi, Timothy R. Lezon. Predicting the Effects of Drug Combinations Using Probabilistic Matrix Factorization. Frontiers in Bioinformatics 2021; 1 doi: 10.3389/fbinf.2021.708815
|
| 45 |
Kembra Albracht-Schulte, Samantha Gonzalez, Abigail Jackson, Savanna Wilson, Latha Ramalingam, Nishan S. Kalupahana, Naima Moustaid-Moussa. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. Nutrients 2019; 11(3): 599 doi: 10.3390/nu11030599
|
| 46 |
Maya Margalit, Hanny Yeshua, Neta Gotlieb, Shira Zelber-Sagi. NAFLD and NASH. 2020; : 11 doi: 10.1007/978-3-030-37173-9_2
|
| 47 |
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy. Toxicology Reports 2021; 8: 376 doi: 10.1016/j.toxrep.2021.02.010
|
| 48 |
O. S. Khukhlina, O. Ye. Hryniuk, A. A. Antoniv. OXIDATIVE STRESS INTENSITY AND STATE OF SEPARATE ANTIOXIDANT PROTECTION FACTORS IN ANTRALE TREATMENT IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS, OBESITY, AND CHRONIC OBSTRUCTIVE LUNG DISEASE. Eastern Ukrainian Medical Journal 2020; 8(2): 129 doi: 10.21272/eumj.2020;8(2):129-136
|
| 49 |
Fu‐Rong Li, Jian Liao, Bin Zhu, Xia Li, Zhiyuan Cheng, Cheng Jin, Chunbao Mo, Xianbo Wu, Qian Li, Fengchao Liang. Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis: A cohort study. Liver International 2023; 43(2): 299 doi: 10.1111/liv.15416
|
| 50 |
Yan Li, Chunyi Wang, Yu Jin, Haibo Chen, Meiqun Cao, Weimin Li, Huanmin Luo, Zhengzhi Wu. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats. Biomedicine & Pharmacotherapy 2020; 126: 109734 doi: 10.1016/j.biopha.2019.109734
|
| 51 |
Carmela Colica, Luigi Boccuto, Ludovico Abenavoli. Silymarin: An option to treat non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(47): 8437-8438 doi: 10.3748/wjg.v23.i47.8437
|
| 52 |
Simon Lam, Stephen Doran, Hatice Hilal Yuksel, Ozlem Altay, Hasan Turkez, Jens Nielsen, Jan Boren, Mathias Uhlen, Adil Mardinoglu. Addressing the heterogeneity in liver diseases using biological networks. Briefings in Bioinformatics 2021; 22(2): 1751 doi: 10.1093/bib/bbaa002
|
| 53 |
Jiaojiao Fu, Jingyan Yang, Liying He, Caixia Yang, Jing He, Yanan Hua, Jinlin Guo, Sijing Liu. Ferulic Acid Alleviates Hepatic Lipid Accumulation and Inflammation by Improving Proximal and Distal Intestinal Barriers in NAFLD Mice. The Tohoku Journal of Experimental Medicine 2023; 260(2): 149 doi: 10.1620/tjem.2023.J023
|
| 54 |
Mohamed Elnagdy, Shirish Barve, Craig McClain, Leila Gobejishvili. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules 2020; 10(10): 1433 doi: 10.3390/biom10101433
|
| 55 |
Yeni Ait Ahmed, Fouad Lafdil, Frank Tacke. Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases. Hepatic Medicine: Evidence and Research 2023; : 113 doi: 10.2147/HMER.S326468
|
| 56 |
Sun Young Park, Ji Eun Kim, He Mi Kang, Ki Ho Park, Byoung Il Je, Ki Won Lee, Dae Youn Hwang, Young Whan Choi. Citrullus mucosospermus Extract Exerts Protective Effects against Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis in Mice. Foods 2024; 13(13): 2101 doi: 10.3390/foods13132101
|
| 57 |
Tahmine Tavakoli, Asghar Zarban, Reyhaneh Hooshyar, Fatemeh Salmani, Hamidreza Tajik. Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone. Archives of Physiology and Biochemistry 2022; 128(6): 1591 doi: 10.1080/13813455.2020.1784953
|
| 58 |
Lijun Xie, Huiying Wang, Jinying Hu, Zhuoying Liu, Fang Hu. The role of novel adipokines and adipose-derived extracellular vesicles (ADEVs): Connections and interactions in liver diseases. Biochemical Pharmacology 2024; 222: 116104 doi: 10.1016/j.bcp.2024.116104
|
| 59 |
Atsuko Kitano, Toshio Norikura, Isao Matsui-Yuasa, Hiromi Shimakawa, Makoto Kamezawa, Akiko Kojima-Yuasa. Phosphodiesterase 4 mRNA Level Suppression is Important for Extract of Black Carrot to Protect Against Hepatic Injury Induced by Ethanol. Journal of Medicinal Food 2022; doi: 10.1089/jmf.2021.K.0186
|
| 60 |
Zhanghao Li, Feixia Wang, Baoyu Liang, Ying Su, Sumin Sun, Siwei Xia, Jiangjuan Shao, Zili Zhang, Min Hong, Feng Zhang, Shizhong Zheng. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00349-7
|
| 61 |
Jin-yu Yang, Min Li, Cheng-liang Zhang, Dong Liu. Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacological Reports 2021; 73(5): 1230 doi: 10.1007/s43440-021-00227-1
|
| 62 |
Qiongdan Hu, Wan Liao, Zhen Zhang, Sanjun Shi, Shuguang Hou, Ningping Ji, Xinjie Zhang, Qian Zhang, Yangyang Liao, Linghui Li, Zongping Zhu, Yi Chen, Jiao Chen, Fangkun Yu, Qingsong Yang, Hongtao Xiao, Chaomei Fu, Hengjun Du, Qi Wang, Heping Cao, Hang Xiao, Rui Li. The hepatoprotective effects of plant-based foods based on the “gut–liver axis”: a prospective review. Critical Reviews in Food Science and Nutrition 2023; 63(28): 9136 doi: 10.1080/10408398.2022.2064423
|
| 63 |
Christine E. Dolin, Toshifumi Sato, Michael L. Merchant, Gavin E. Arteel. Extracellular Matrix Omics. Biology of Extracellular Matrix 2020; 7: 43 doi: 10.1007/978-3-030-58330-9_3
|
| 64 |
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi, Ilaria Demori. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. Planta Medica 2022; 88(01): 9 doi: 10.1055/a-1273-3159
|
| 65 |
Lampros G. Chrysavgis, Spyridon Kazanas, Konstantina Bafa, Sophia Rozani, Maria-Evangelia Koloutsou, Evangelos Cholongitas. Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature. International Journal of Molecular Sciences 2024; 25(7): 3832 doi: 10.3390/ijms25073832
|
| 66 |
Farhin Patel, Kirti Parwani, Priyashi Rao, Dhara Patel, Rakesh Rawal, Palash Mandal, Sanjoy Roychowdhury. Prophylactic Treatment of Probiotic and Metformin Mitigates Ethanol-Induced Intestinal Barrier Injury: In Vitro, In Vivo, and In Silico Approaches. Mediators of Inflammation 2021; 2021: 1 doi: 10.1155/2021/5245197
|
| 67 |
Vladimir T. Ivashkin, Marina V. Maevskaya, Elena N. Shirokova, Igor V. Maev, Alexey A. Samsonov, Evgeniy I. Sas, Liudmila K. Palgova, Kirill Starostin. Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies. Drugs - Real World Outcomes 2021; 8(3): 369 doi: 10.1007/s40801-021-00250-x
|
| 68 |
Madan Kumar Arumugam, Matthew C. Paal, Terrence M. Donohue, Murali Ganesan, Natalia A. Osna, Kusum K. Kharbanda. Beneficial Effects of Betaine: A Comprehensive Review. Biology 2021; 10(6): 456 doi: 10.3390/biology10060456
|
| 69 |
Shenghong Sun, Ding Shi, Wei Wang. Risk of chronic liver disease and cirrhosis mortality among patients with digestive system cancers: a registry-based analysis. Clinical and Experimental Medicine 2023; 23(8): 5355 doi: 10.1007/s10238-023-01199-7
|
| 70 |
Qi Zhang, Jie Wen, Jianhang Zhou, Bob Zhang. Missing-view completion for fatty liver disease detection. Computers in Biology and Medicine 2022; 150: 106097 doi: 10.1016/j.compbiomed.2022.106097
|
| 71 |
Na Li, Lin Yin, Jiamin Shang, Meidai Liang, Zhaoyu Liu, Haiguang Yang, Guifen Qiang, Guanhua Du, Xiuying Yang. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway. Biomedicine & Pharmacotherapy 2023; 165: 115113 doi: 10.1016/j.biopha.2023.115113
|
| 72 |
Ming-Fo Hsu, Shinichiro Koike, Aline Mello, Laura E. Nagy, Fawaz G. Haj. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice. Redox Biology 2020; 36: 101658 doi: 10.1016/j.redox.2020.101658
|
| 73 |
Xiaoqing Li, Yu Su, Xinyue Zhao, Hongguang Zhu, Zichao Li. Effects of Flavonoids on Alcoholic Liver Disease: A Review. Food Reviews International 2024; : 1 doi: 10.1080/87559129.2024.2390557
|
| 74 |
Karli R. LeFort, Wiramon Rungratanawanich, Byoung-Joon Song. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-023-05061-7
|
| 75 |
Myeong Seon Jeong, SeonJu Park, Eui Jeong Han, Soo Yeon Park, Min Ju Kim, Kyungsook Jung, Su-Hyeon Cho, Seo-Young Kim, Weon-Jong Yoon, Ginnae Ahn, Kil-Nam Kim. Pinus thunbergii PARL leaf protects against alcohol-induced liver disease by enhancing antioxidant defense mechanism in BALB/c mice. Journal of Functional Foods 2020; 73: 104116 doi: 10.1016/j.jff.2020.104116
|
| 76 |
Fotian Xie, Yuanming Zhong, Dongmei Wang, Kwok Fai So, Jia Xiao, Yi Lv. Metformin protects against ethanol-induced liver triglyceride accumulation by the LKB1/AMPK/ACC pathway. Molecular Biology Reports 2022; 49(8): 7837 doi: 10.1007/s11033-022-07610-y
|
| 77 |
Ruozhi Zhao, Bo Xiang, Vernon W. Dolinsky, Min Xia, Garry X. Shen. Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice. The Journal of Nutritional Biochemistry 2021; 95: 108778 doi: 10.1016/j.jnutbio.2021.108778
|
| 78 |
A A Svistunov, M A Osadchuk, N V Kireeva, M M Osadchuk. Optimizing therapy of liver diseases not associated with viral infection. Terapevticheskii arkhiv 2018; 90(2): 94 doi: 10.26442/terarkh2018902105-111
|
| 79 |
Mengyi Liu, Ziliang Ye, Yuanyuan Zhang, Panpan He, Chun Zhou, Sisi Yang, Yanjun Zhang, Xiaoqin Gan, Xianhui Qin. Accelerometer-derived moderate-to-vigorous physical activity and incident nonalcoholic fatty liver disease. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03618-2
|
| 80 |
Xingfei Lai, Xinrong Wang, Shuai Wen, Lingli Sun, Ruohong Chen, Zhenbiao Zhang, Qiuhua Li, Junxi Cao, Zhaoxiang Lai, Zhigang Li, Shili Sun, Xiaohui Liu. Six Types of Tea Reduce Acute Alcoholism in Mice by Enhancing Ethanol Metabolism, Suppressing Oxidative Stress and Inflammation. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.848918
|
| 81 |
Lorena Fecury Tavares, Mariana Rosa Bernardo, Kalil Orleans Silveira Pinho, Ana Paula Santos Oliveira Brito, Rodrigo Bona Maneschy, Hamilton Cezar Rocha de Garcia. Doença Hepática Gordurosa Não Alcoólica - Diagnóstico e tratamento. Pará Research Medical Journal 2022; 3(2): 1 doi: 10.4322/prmj.2019.011
|
| 82 |
Jeffrey Barr Warner, Steven Corrigan Guenthner, Josiah Everett Hardesty, Craig James McClain, Dennis Ray Warner, Irina Andreyevna Kirpich. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World Journal of Gastroenterology 2022; 28(36): 5280-5299 doi: 10.3748/wjg.v28.i36.5280
|
| 83 |
Sharanappa T. Talawar, Kiran Gangappa, Sharavana Gurunathan, Mayookha V.P, Suresh Kumar Gurusiddaiah. Sterol Ferulate Rich Wheat Bran Oil Concentrate Prevents Liver Damage in MAFLD Mouse Model by Modulating FAS and PCSK9. ACS Food Science & Technology 2021; 1(4): 644 doi: 10.1021/acsfoodscitech.0c00156
|
| 84 |
Chen Xue, Xinyu Gu, Ganglei Li, Zhengyi Bao, Lanjuan Li. Mitochondrial Mechanisms of Necroptosis in Liver Diseases. International Journal of Molecular Sciences 2020; 22(1): 66 doi: 10.3390/ijms22010066
|
| 85 |
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, Jin Wang. Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(3): 2844 doi: 10.3390/ijms24032844
|
| 86 |
Jui-Ting Hu, Sien-Sing Yang. Variceal Bleeding in Liver Cirrhosis. 2021; : 41 doi: 10.1007/978-981-15-7249-4_4
|
| 87 |
Xiaohua Huang, Dawadschargal Dubiel, Wolfgang Dubiel. The COP9 Signalosome Variant CSNCSN7A Stabilizes the Deubiquitylating Enzyme CYLD Impeding Hepatic Steatosis. Livers 2021; 1(3): 116 doi: 10.3390/livers1030011
|
| 88 |
Duck-Pil Ok, Kangeun Ko, Ju Yong Bae. Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0852-z
|
| 89 |
Yu-Han Hung, Matt Kanke, Catherine Lisa Kurtz, Rebecca L. Cubitt, Rodica P. Bunaciu, Liye Zhou, Phillip J. White, Kasey C. Vickers, Mohammed Mahmood Hussain, Xiaoling Li, Praveen Sethupathy. MiR-29 Regulates de novo Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01367
|
| 90 |
Xiaoxia Wang, Xuhong Chang, Haibing Zhan, Qiong Zhang, Chengyun Li, Qing Gao, Mengmeng Yang, Zhen Luo, Sheng Li, Yingbiao Sun. Curcumin and Baicalin ameliorate ethanol‐induced liver oxidative damage via the Nrf2/HO‐1 pathway. Journal of Food Biochemistry 2020; 44(10) doi: 10.1111/jfbc.13425
|
| 91 |
Lina Kong, Renchao Dong, Kai Huang, Xiaohui Wang, Dalong Wang, Nan Yue, Changyuan Wang, Pengyuan Sun, Jiangning Gu, Haifeng Luo, Kexin Liu, Jingjing Wu, Huijun Sun, Qiang Meng. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR. Phytomedicine 2021; 90: 153629 doi: 10.1016/j.phymed.2021.153629
|
| 92 |
Phaniendra Alugoju, V. K. D. Krishna Swamy, Naga Venkata Anusha Anthikapalli, Tewin Tencomnao. Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review. Critical Reviews in Food Science and Nutrition 2023; 63(31): 10709 doi: 10.1080/10408398.2022.2084600
|
| 93 |
Sofia Lachiondo-Ortega, Maria Mercado-Gómez, Marina Serrano-Maciá, Fernando Lopitz-Otsoa, Tanya B Salas-Villalobos, Marta Varela-Rey, Teresa C. Delgado, María Luz Martínez-Chantar. Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. Cells 2019; 8(12): 1575 doi: 10.3390/cells8121575
|
| 94 |
Inyong Jung, Hyerin Kim, Seongcheol Moon, Hyuk Lee, Bonglee Kim. Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action. Antioxidants 2020; 9(9): 857 doi: 10.3390/antiox9090857
|
| 95 |
Lugao Tian, Fachao Fan, Shihua Zheng, Qiaoyun Tong. Puerarin Exerts the Hepatoprotection from Chronic Alcohol-Induced Liver Injury via Inhibiting the Cyclooxygenase-2 and the 5-Lipoxygenase Pathway in Rats. Complementary Medicine Research 2021; 28(2): 104 doi: 10.1159/000508686
|
| 96 |
Man Na, Xingbiao Yang, Yongkun Deng, Zhaoheng Yin, Mingwei Li. Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease. PeerJ 2023; 11: e16398 doi: 10.7717/peerj.16398
|
| 97 |
Cecilia Östlund, Antonio Hernandez-Ono, Ji-Yeon Shin. The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD. Biology 2020; 9(10): 338 doi: 10.3390/biology9100338
|
| 98 |
Lizhu Han, Liuyun Wu, Qinan Yin, Lian Li, Xingyue Zheng, Shan Du, Xuefei Huang, Lan Bai, Yi Wang, Yuan Bian. A promising therapy for fatty liver disease: PCSK9 inhibitors. Phytomedicine 2024; 128: 155505 doi: 10.1016/j.phymed.2024.155505
|
| 99 |
Bo Yoon Chang, Jin Hye Bae, Cho Young Lim, Yoon Hee Kim, Tae Young Kim, Sung Yeon Kim. Tricin-enriched Zizania latifolia ameliorates non-alcoholic fatty liver disease through AMPK-dependent pathways. Food Science and Biotechnology 2023; 32(14): 2117 doi: 10.1007/s10068-023-01311-3
|
| 100 |
Qi Zhang, Shuang Wu, Qiubing Chen, Yahong Zhang, Cai Zhang, Runting Yin, Zhen Ouyang, Yuan Wei. Reducing Oxidative Stress-Mediated Alcoholic Liver Injury by Multiplexed RNAi of Cyp2e1, Cyp4a10, and Cyp4a14. Biomedicines 2024; 12(7): 1505 doi: 10.3390/biomedicines12071505
|
| 101 |
Janjira Prasomthong, Nanteetip Limpeanchob, Supawadee Daodee, Pennapa Chonpathompikunlert, Sakara Tunsophon. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11027-9
|
| 102 |
Junlin Yan, Rui Zhang, Jinsen Kang, Yewei Zhong, Adalaiti Abudurexiti, Huiwen Tan, Yi Lei, Xiaoli Ma. Effect of Cichorium glandulosum on intestinal microbiota and bile acid metabolism in db/db mice. Food Science & Nutrition 2023; 11(12): 7765 doi: 10.1002/fsn3.3694
|
| 103 |
Manhong Ye, Mengting Xu, Shuhang Fan, Mengjie Zhang, Bin Zhou, Shengmei Yang, Wanhong Wei, Chao Ji, Jian Ji, Fubiao Ji. Protective effects of three propolis-abundant flavonoids against ethanol-induced injuries in HepG2 cells involving the inhibition of ERK1/2-AHR-CYP1A1 signaling pathways. Journal of Functional Foods 2020; 73: 104166 doi: 10.1016/j.jff.2020.104166
|
| 104 |
Igor V. Maev, Alexey O. Bueverov, Artem V. Volnukhin. Efficacy and Safety of a Fixed Combination of Glycyrrhizic Acid and Essential Phospholipids in Non-Alcoholic Fatty and Alcoholic Liver Disease: Results from Randomized Placebo-Controlled Trials. Annals of the Russian academy of medical sciences 2021; 76(6): 595 doi: 10.15690/vramn1576
|
| 105 |
Feng Xu, Zengqiang Chen, Longteng Xie, Shizhuo Yang, Yuying Li, Junnan Wu, Yuyu Wu, Siyuan Li, Xie Zhang, Yanyan Ma, Yanlong Liu, Aibing Zeng, Zeping Xu. Lactobacillus plantarum ST-III culture supernatant protects against acute alcohol-induced liver and intestinal injury. Aging 2023; doi: 10.18632/aging.205331
|
| 106 |
Qiyu Pan, Tingting Han, Guoping Li. Novel insights into the roles of tRNA-derived small RNAs. RNA Biology 2021; 18(12): 2157 doi: 10.1080/15476286.2021.1922009
|
| 107 |
Konstantinos Kounakis, Manos Chaniotakis, Maria Markaki, Nektarios Tavernarakis. Emerging Roles of Lipophagy in Health and Disease. Frontiers in Cell and Developmental Biology 2019; 7 doi: 10.3389/fcell.2019.00185
|
| 108 |
Lan Bai, Hongliang Li. Innate immune regulatory networks in hepatic lipid metabolism. Journal of Molecular Medicine 2019; 97(5): 593 doi: 10.1007/s00109-019-01765-1
|
| 109 |
Mehdi Afsharinasab, Maryam Mohammad-Sadeghipour, Mohammad Reza Hajizadeh, Alireza Khoshdel, Vahid Mirzaiey, Mehdi Mahmoodi. The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease. Saudi Journal of Biological Sciences 2020; 27(8): 2031 doi: 10.1016/j.sjbs.2020.04.037
|
| 110 |
Priyanka Bhandari, Amit Sapra, Mohitkumar S Ajmeri, Christine E Albers, Devanshika Sapra. Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?. Cureus 2022; doi: 10.7759/cureus.23806
|
| 111 |
Ahmad Anouti, Jessica L. Mellinger. The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors. Seminars in Liver Disease 2023; 43(01): 050 doi: 10.1055/a-2000-6680
|
| 112 |
Khushboo S. Gala, Vatsalya Vatsalya. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope. Cells 2020; 9(3): 524 doi: 10.3390/cells9030524
|
| 113 |
Daria A. Teplyuk, Aliya A. Kaisina, Shabnam I. Ibragimova, Afina A. Bestavashvili, Irina O. Tinkova, Evgeniia Iu. Pashkova, Jamilya A. Kaibullayeva, Alexander V. Nersesov, Chavdar S. Pavlov. Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review. Consilium Medicum 2023; 25(5): 325 doi: 10.26442/20751753.2023.5.202272
|
| 114 |
S. Zhu, Z. Wu, W. Wang, L. Wei, H. Zhou. A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials. Journal of Endocrinological Investigation 2023; 47(4): 761 doi: 10.1007/s40618-023-02216-y
|
| 115 |
Lei Song, Ming Li, Chi Feng, Rigaiqiqige Sa, Xiaodong Hu, Jie Wang, Xiaoyu Yin, Chelimuge Qi, Wu Dong, Jingfeng Yang. Protective effect of curcumin on zebrafish liver under ethanol-induced oxidative stress. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2022; 258: 109360 doi: 10.1016/j.cbpc.2022.109360
|
| 116 |
Xinling Song, Wenxue Sun, Weijun Cui, Le Jia, Jianjun Zhang. A polysaccharide of PFP-1 from Pleurotus geesteranus attenuates alcoholic liver diseases via Nrf2 and NF-κB signaling pathways. Food & Function 2021; 12(10): 4591 doi: 10.1039/D1FO00310K
|
| 117 |
Jia-Hung Lin, Chi-Huei Lin, Yi-Wei Kuo, Chorng-An Liao, Jui-Fen Chen, Shin-Yu Tsai, Ching-Min Li, Yu-Chieh Hsu, Yen-Yu Huang, Ko-Chiang Hsia, Yao-Tsung Yeh, Hsieh-Hsun Ho, Imad Al Kassaa. Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study. PLOS ONE 2024; 19(7): e0307181 doi: 10.1371/journal.pone.0307181
|
| 118 |
Xuling Liu, Guangyue Yang, Tiantian Sun, Le Tao, Dongxiao Shen, Wei Zhang, Jie Zhang, Dongying Xue, Bei Chen, Liu Wu, Cheng Liu, Wenting Ma. Glial cell line‐derived neurotrophic factor contributes to alcoholic‐induced liver injury by regulating the NF‐κB pathway. Alcoholism: Clinical and Experimental Research 2022; 46(5): 724 doi: 10.1111/acer.14815
|
| 119 |
Farhin Patel, Kirti Parwani, Dhara Patel, Palash Mandal, Muthuraju Sangu. Metformin and Probiotics Interplay in Amelioration of Ethanol-Induced Oxidative Stress and Inflammatory Response in an In Vitro and In Vivo Model of Hepatic Injury. Mediators of Inflammation 2021; 2021: 1 doi: 10.1155/2021/6636152
|
| 120 |
Xingran Chen, Mianli Bian, Huanhuan Jin, Naqi Lian, Jiangjuan Shao, Feng Zhang, Shizhong Zheng. Dihydroartemisinin attenuates alcoholic fatty liver through regulation of lipin‐1 signaling. IUBMB Life 2019; 71(11): 1740 doi: 10.1002/iub.2113
|
| 121 |
Xianyu Huang, Shan Yang, Jian Sun, Xia Li, Shao-Yu Zhou, Jing-Shan Shi, Jie Liu, Qin Wu. Transcriptome Analysis of Protection by Dendrobium nobile Alkaloids (DNLA) against Chronic Alcoholic Liver Injury in Mice. Biomedicines 2022; 10(11): 2800 doi: 10.3390/biomedicines10112800
|
| 122 |
Xiaoping Gao, Jun Liu, Yuanning Luo, Yu Lei, Wenwen Long, Kai Wang, Jian Zhou, Ming Lei, Nan Yang, Hongyu Zou, Feihong Huang, Runlan Wan. Various Fractions of Alcoholic Extracts from Dendrobium nobile Functionalized Antioxidation and Antiaging in D-Galactose-Induced Aging Mice. Frontiers in Bioscience-Landmark 2022; 27(11) doi: 10.31083/j.fbl2711315
|
| 123 |
T.I. Yefimenko, M.R. Mykytyuk. Non-alcoholic fatty liver disease: time for changes. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2021; 17(4): 334 doi: 10.22141/2224-0721.17.4.2021.237350
|
| 124 |
Albert Gibert-Ramos, David Sanfeliu-Redondo, Peio Aristu-Zabalza, Ana Martínez-Alcocer, Jordi Gracia-Sancho, Sergi Guixé-Muntet, Anabel Fernández-Iglesias. The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer. Cancers 2021; 13(22): 5719 doi: 10.3390/cancers13225719
|
| 125 |
Joon Hee Han, Min Hong, Hoang Viet Bach Khoa, Luong Van Dung, Tae Hyung Kwon, Soo Ung Lee. Antioxidant and Hepatoprotective Effects of Kadsura coccinea Stem Extract on Oxidative Damage on HepG2 Cells. Korean Journal of Medicinal Crop Science 2024; 32(1): 1 doi: 10.7783/KJMCS.2024.32.1.1
|
| 126 |
Punyaban Patel, Borra Sivaiah, Riyam Patel. Intelligent Systems. Lecture Notes in Networks and Systems 2022; 431: 665 doi: 10.1007/978-981-19-0901-6_58
|
| 127 |
Emir Muzurović, Stergios A. Polyzos, Dimitri P. Mikhailidis, Sanja Borozan, Dušanka Novosel, Oleg Cmiljanić, Nataša Kadić, Christos S. Mantzoros. Non-alcoholic Fatty Liver Disease in Children. Current Vascular Pharmacology 2023; 21(1): 4 doi: 10.2174/1570161121666221118155136
|
| 128 |
Vetriselvan Subramaniyan, Natasha Sura Anak Lubau, Nobendu Mukerjee, Vinoth Kumarasamy. Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potential. Toxicology Reports 2023; 11: 355 doi: 10.1016/j.toxrep.2023.10.005
|
| 129 |
Weimin Wan, Riming Wei, Baoling Xu, Houkang Cao, Yueping Zhi, Fengyue Guo, Haiping Liu, Bo Li, Jianzhao Wu, Ya Gao, Kefeng Zhang. Qiwei Jinggan Ling regulates oxidative stress and lipid metabolism in alcoholic liver disease by activating AMPK. Phytomedicine 2024; 135: 156125 doi: 10.1016/j.phymed.2024.156125
|
| 130 |
Fei Zhao, Jinjing Ke, Wensheng Pan, Hanghai Pan, Miao Shen. Synergistic effects of ISL1 and KDM6B on non-alcoholic fatty liver disease through the regulation of SNAI1. Molecular Medicine 2022; 28(1) doi: 10.1186/s10020-021-00428-7
|
| 131 |
Bohumil Seifert. Hepatoprotectives and their use in general practice. Medicína pro praxi 2019; 16(1): 20 doi: 10.36290/med.2019.046
|
| 132 |
Haoyu Wang, Junqi Zhao, Shiliang Ji, Tingjun Liu, Zhisheng Cheng, Zhen Huang, Yuhui Zang, Jiangning Chen, Junfeng Zhang, Zhi Ding. Metallofullerenol alleviates alcoholic liver damage via ROS clearance under static magnetic and electric fields. Free Radical Biology and Medicine 2024; 220: 236 doi: 10.1016/j.freeradbiomed.2024.05.003
|
| 133 |
Aline Mello, Ming-Fo Hsu, Shinichiro Koike, Bryan Chu, Jeff Cheng, Jun Yang, Christophe Morisseau, Natalie J. Torok, Bruce D. Hammock, Fawaz G. Haj. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2021; 11(3): 815 doi: 10.1016/j.jcmgh.2020.10.002
|
| 134 |
Chuyun Yan, Wanting Hu, Jinqi Tu, Jinyao Li, Qionglin Liang, Shuxin Han. Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04166-8
|
| 135 |
Marina Parra-Robert, Eudald Casals, Nuria Massana, Muling Zeng, Meritxell Perramón, Guillermo Fernández-Varo, Manuel Morales-Ruiz, Víctor Puntes, Wladimiro Jiménez, Gregori Casals. Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis. Biomolecules 2019; 9(9): 425 doi: 10.3390/biom9090425
|
| 136 |
Harsh Kumar, Daljeet Singh Dhanjal, Shivani Guleria, Eugenie Nepovimova, Nidhi Sethi, Rajni Dhalaria, Kamil Kuca. Hepatoprotective effects of fruits pulp, seed, and peel against chemical-induced toxicity: Insights from in vivo studies. Food and Chemical Toxicology 2024; 189: 114742 doi: 10.1016/j.fct.2024.114742
|
| 137 |
Isis Janilkarn-Urena, Alina Idrissova, Mindy Zhang, Masha VanDreal, Neysa Sanghavi, Samantha G. Skinner, Sydney Cheng, Zeyu Zhang, Junji Watanabe, Liana Asatryan, Enrique Cadenas, Daryl L. Davies. Dihydromyricetin supplementation improves ethanol-induced lipid accumulation and inflammation. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1201007
|
| 138 |
Wenhui Li, Zhaoyue Liu, Fengwei Tang, Hao Jiang, Zhengyuan Zhou, Xiuqing Hao, Jia Ming Zhang. Application of 3D Bioprinting in Liver Diseases. Micromachines 2023; 14(8): 1648 doi: 10.3390/mi14081648
|
| 139 |
Tingting Shi, Li Wu, Wenjun Ma, Liping Ju, Minghui Bai, Xiaowei Chen, Shourong Liu, Xingxin Yang, Junping Shi, Svein Haavik. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/8749564
|
| 140 |
|
| 141 |
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip, Alessandro Granito. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/4344905
|
| 142 |
Ruohong Chen, Yingyi Lian, Shuai Wen, Qiuhua Li, Lingli Sun, Xingfei Lai, Zhenbiao Zhang, Junquan Zhu, Linsong Tang, Ji Xuan, Erdong Yuan, Shili Sun. Shibi Tea (Adinandra nitida) and Camellianin A Alleviate CCl4-Induced Liver Injury in C57BL-6J Mice by Attenuation of Oxidative Stress, Inflammation, and Apoptosis. Nutrients 2022; 14(15): 3037 doi: 10.3390/nu14153037
|
| 143 |
Seung-Joon Paek, Sang-Hyun Lee, Jung Su Park, Jun-Soo Kim, Dong-Ho Park. The Effects of Turmeric Intake Alone or in Combination with Resistance Training on Liver Enzymes in Adult Men. Exercise Science 2021; 30(2): 183 doi: 10.15857/ksep.2021.30.2.183
|
| 144 |
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression. Pathology - Research and Practice 2023; 251: 154809 doi: 10.1016/j.prp.2023.154809
|
| 145 |
Ahmad Hormati, Fatemeh Tooiserkany, Abolfazl Mohammadbeigi, Fatemeh Aliasl, Hossein Moradi Dehnavi. Effect of an Herbal Product on the Serum Level of Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Trial. Iranian Red Crescent Medical Journal 2019; 21(7) doi: 10.5812/ircmj.91024
|
| 146 |
Robert F. Schwabe, Tom Luedde. Apoptosis and necroptosis in the liver: a matter of life and death. Nature Reviews Gastroenterology & Hepatology 2018; 15(12): 738 doi: 10.1038/s41575-018-0065-y
|
| 147 |
Andrew S. Bell, Emma M. O’Connell, Falk W. Lohoff. Cholesterol. 2022; : 747 doi: 10.1016/B978-0-323-85857-1.00036-5
|
| 148 |
Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD). Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2331460
|
| 149 |
Bo Yoon Chang, Hyung Joong Kim, Tae Young Kim, Sung Yeon Kim. Enzyme-Treated Zizania latifolia Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 Pathway. Antioxidants 2021; 10(6): 960 doi: 10.3390/antiox10060960
|
| 150 |
Camelia Munteanu, Betty Schwartz. The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease. Antioxidants 2023; 12(4): 903 doi: 10.3390/antiox12040903
|
| 151 |
Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Ali Mottaghi-Moghaddam, Fatemeh Goldani, Majid Khazaei, Majid Ghayour-Mobarhan, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(7): 633 doi: 10.1080/17474124.2019.1617696
|
| 152 |
He Zhang, Liying Yang, Yichao Wang, Wenli Huang, Yang Li, Shuchun Chen, Guangyao Song, Luping Ren. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease. Life Sciences 2020; 257: 118090 doi: 10.1016/j.lfs.2020.118090
|
| 153 |
Young-Hee Yoon, Chiung M. Chen, Megan E. Slater, M. Katherine Jung, Aaron M. White. Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999–2018. American Journal of Preventive Medicine 2020; 59(4): 469 doi: 10.1016/j.amepre.2020.04.024
|
| 154 |
Paul J. Fitzgerald. Is There a Novel Biosynthetic Pathway in Mice That Converts Alcohol to Dopamine, Norepinephrine and Epinephrine?. Molecules 2022; 27(9): 2726 doi: 10.3390/molecules27092726
|
| 155 |
Norbert Stefan, Marek Hartleb, Branko Popovic, Rafael Varona. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial. Trials 2024; 25(1) doi: 10.1186/s13063-024-08208-4
|
| 156 |
Muhammad A. Alsherbiny, Wessam H. Abd-Elsalam, Shymaa A. El badawy, Ehab Taher, Mohamed Fares, Allan Torres, Dennis Chang, Chun Guang Li. Ameliorative and protective effects of ginger and its main constituents against natural, chemical and radiation-induced toxicities: A comprehensive review. Food and Chemical Toxicology 2019; 123: 72 doi: 10.1016/j.fct.2018.10.048
|
| 157 |
Meng-ya Shan, Ying Dai, Xiao-dan Ren, Jing Zheng, Ke-bin Zhang, Bin Chen, Jun Yan, Zi-hui Xu. Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. Journal of Integrative Medicine 2021; 19(6): 545 doi: 10.1016/j.joim.2021.09.003
|
| 158 |
Dhara Patel, Chirayu Desai, Deepmala Singh, Virupakshi Soppina, Kirti Parwani, Farhin Patel, Palash Mandal. Synbiotic Intervention Ameliorates Oxidative Stress and Gut Permeability in an In Vitro and In Vivo Model of Ethanol-Induced Intestinal Dysbiosis. Biomedicines 2022; 10(12): 3285 doi: 10.3390/biomedicines10123285
|
| 159 |
Anmol Singh, Aalam Sohal, Akash Batta. GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis. World Journal of Gastroenterology 2024; 30(48): 5205-5211 doi: 10.3748/wjg.v30.i48.5205
|
| 160 |
Na-kyung Cho, Yu-ri Lee, Kyung-soon Kim, Hong-sik Choi, Seung-mo Kim, Young-doo Back, Byung-kwon Moon. A Review of Domestic Research on Traditional Korean Medicine for Alcoholic Liver Disease. The Journal of Internal Korean Medicine 2019; 40(3): 458 doi: 10.22246/jikm.2019.40.3.458
|
| 161 |
Zhi‐Bin Jiang, Jie Gao, Yi‐Hui Chai, Wen Li, Yun‐Feng Luo, Yun‐Zhi Chen. Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress. The Kaohsiung Journal of Medical Sciences 2021; 37(8): 718 doi: 10.1002/kjm2.12390
|
| 162 |
Ying-Ying Tan, Ying-Ying Liu, Yi-Yan Zhai, Yi-Xuan Wang, Zhi-Shan Wu, Antony Stalin, Guo-Liang Cheng, Bing Li, Chao Wu, Zhi-Hong Huang, Shan Lu, Xiao-Tian Fan, Zheng Zhao, Jia-Rui Wu. Investigating the Potential Mechanism of Huazhi Rougan Granules Against Alcoholic Liver Disease by Network Pharmacology and Experiment. World Journal of Traditional Chinese Medicine 2024; 10(2): 191 doi: 10.4103/wjtcm.wjtcm_34_23
|
| 163 |
Min Guo, Liwei Gu, Heping Hui, Xiaodong Li, Ling Jin. Extracts of Dracocephalum tanguticum Maxim Ameliorate Acute Alcoholic Liver Disease via Regulating Transcription Factors in Mice. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.830532
|
| 164 |
Hongbo Du, Hao Yu, Meiyue Zhou, Quan Hui, Yixin Hou, Yuyong Jiang. The effect of STAT1, miR-99b, and MAP2K1 in alcoholic liver disease (ALD) mouse model and hepatocyte. Aging 2024; doi: 10.18632/aging.205579
|
| 165 |
V. V. Bortnikova, V. V. Karabaeva, L. V. Krepkova, P. G. Mizina, A. N. Babenko, N. S. Mikheeva, O. N. Karabaeva. A Retrospective Analysis of the Clinical Studies of a Drug "Flakozid" in the Treatment of Diseases of the Hepatobiliary System. Drug development & registration 2021; 10(3): 100 doi: 10.33380/2305-2066-2021-10-3-100-104
|
| 166 |
Jing Lu, Xiaoyu Zhu, Chong Zhang, Fengxia Lu, Zhaoxin Lu, Yingjian Lu. Co-expression of alcohol dehydrogenase and aldehyde dehydrogenase in Bacillus subtilis for alcohol detoxification. Food and Chemical Toxicology 2020; 135: 110890 doi: 10.1016/j.fct.2019.110890
|
| 167 |
Tom H Karlsen, Nick Sheron, Shira Zelber-Sagi, Patrizia Carrieri, Geoffrey Dusheiko, Elisabetta Bugianesi, Rachel Pryke, Sharon J Hutchinson, Bruno Sangro, Natasha K Martin, Michele Cecchini, Mae Ashworth Dirac, Annalisa Belloni, Miquel Serra-Burriel, Cyriel Y Ponsioen, Brittney Sheena, Alienor Lerouge, Marion Devaux, Nick Scott, Margaret Hellard, Henkjan J Verkade, Ekkehard Sturm, Giulio Marchesini, Hannele Yki-Järvinen, Chris D Byrne, Giovanni Targher, Aviad Tur-Sinai, Damon Barrett, Michael Ninburg, Tatjana Reic, Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra, Michael P Manns. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. The Lancet 2022; 399(10319): 61 doi: 10.1016/S0140-6736(21)01701-3
|
| 168 |
Aaliya L. Ali, Namrata P. Nailwal, Gaurav M. Doshi. Emerging Role of Interleukins for the Assessment and Treatment of Liver
Diseases. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(4): 371 doi: 10.2174/1871530321666211124102837
|
| 169 |
Yusef M Alenezi, Rebecca Harris, Joanne Morling, Tim Card. Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis. Cureus 2023; doi: 10.7759/cureus.40308
|
| 170 |
Yukun Li, Miaomiao Wei, Qi Yuan, Yu Liu, Tian Tian, Lingling Hou, Jinhua Zhang. MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway. Journal of Molecular Medicine 2022; 100(7): 1071 doi: 10.1007/s00109-022-02196-1
|
| 171 |
Cosimo Colletta, Alessandro Colletta, Giuseppe Placentino. Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease. Journal of Diabetes & Metabolic Disorders 2020; 19(2): 883 doi: 10.1007/s40200-020-00576-3
|
| 172 |
Jin Young Suh, Hyo‐Jung Lee, Deok Yong Sim, Ji Eon Park, Chi‐Hoon Ahn, Su‐Yeon Park, Nari Shin, Bonglee Kim, Bum Sang Shim, Sung‐Hoon Kim. Hypolipogenic effects of Icariside E4 via phosphorylation of AMPK and inhibition of MID1IP1 in HepG2 cells. Phytotherapy Research 2023; 37(1): 7 doi: 10.1002/ptr.7584
|
| 173 |
Acharya Balkrishna, Vivek Gohel, Rani Singh, Kunal Bhattacharya, Anurag Varshney. Livogrit ameliorates acetaldehyde-induced steatosis in HepG2 cells through modulation of lipogenesis and β-oxidation pathways. Phytomedicine Plus 2021; 1(3): 100067 doi: 10.1016/j.phyplu.2021.100067
|
| 174 |
Min Wei, Ting Li, Houkang Cao, Haiyan He, Chaoyue Yang, Yifan Yin, Huijie Lu, Petr Novák, Kefeng Zhang, Ya Gao. The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing. Biomedicine & Pharmacotherapy 2022; 155: 113770 doi: 10.1016/j.biopha.2022.113770
|